[
  {
    "ts": null,
    "headline": "Gilead Sciences (GILD) Tops Q4 Earnings and Revenue Estimates",
    "summary": "Gilead (GILD) delivered earnings and revenue surprises of 13.77% and 7.27%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=e27f77bce6c47da48a73dc0823c6d5f0f731a8e5cbed2a7ec04bd6c616415c85",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739311805,
      "headline": "Gilead Sciences (GILD) Tops Q4 Earnings and Revenue Estimates",
      "id": 132766605,
      "image": "https://media.zenfs.com/en/zacks.com/b369e357aa3d42cc28ac674490d4ae83",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead (GILD) delivered earnings and revenue surprises of 13.77% and 7.27%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=e27f77bce6c47da48a73dc0823c6d5f0f731a8e5cbed2a7ec04bd6c616415c85"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences, Inc. 2024 Q4 - Results - Earnings Call Presentation",
    "summary": "The following slide deck was published by Gilead Sciences, Inc.",
    "url": "https://finnhub.io/api/news?id=108a4c3dfef394863a462589c5e982cc3eec047490441f52fdac9cedfb286cd7",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739306532,
      "headline": "Gilead Sciences, Inc. 2024 Q4 - Results - Earnings Call Presentation",
      "id": 132677136,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "The following slide deck was published by Gilead Sciences, Inc.",
      "url": "https://finnhub.io/api/news?id=108a4c3dfef394863a462589c5e982cc3eec047490441f52fdac9cedfb286cd7"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences, Inc. (GILD) Q4 2024 Earnings Call Transcript",
    "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) Q4 2024 Earnings Conference Call February 11, 2025 4:30 PM ETCompany ParticipantsJacquie Ross - SVP, Treasury &amp;...",
    "url": "https://finnhub.io/api/news?id=f88bc1af0395fd1848c18d558bb8fa9c2d82cce836878ec2cb98936f8a44debf",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739306437,
      "headline": "Gilead Sciences, Inc. (GILD) Q4 2024 Earnings Call Transcript",
      "id": 132677138,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) Q4 2024 Earnings Conference Call February 11, 2025 4:30 PM ETCompany ParticipantsJacquie Ross - SVP, Treasury &amp;...",
      "url": "https://finnhub.io/api/news?id=f88bc1af0395fd1848c18d558bb8fa9c2d82cce836878ec2cb98936f8a44debf"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Beats Earnings Estimates on Strong HIV Sales. The Stock Is Rising.",
    "summary": "Gilead Beats Earnings Estimates on Strong HIV Sales. The Stock Is Rising.",
    "url": "https://finnhub.io/api/news?id=f40787dc07e3b82cb29e5410ef6cc2153ce92dcb34dc552e925332e75a3cf2aa",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739290080,
      "headline": "Gilead Beats Earnings Estimates on Strong HIV Sales. The Stock Is Rising.",
      "id": 134149036,
      "image": "",
      "related": "GILD",
      "source": "MarketWatch",
      "summary": "Gilead Beats Earnings Estimates on Strong HIV Sales. The Stock Is Rising.",
      "url": "https://finnhub.io/api/news?id=f40787dc07e3b82cb29e5410ef6cc2153ce92dcb34dc552e925332e75a3cf2aa"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences 4Q Profit Up on HIV Product Sales, Dividend Raised",
    "summary": "Gilead Sciences 4Q Profit Up on HIV Product Sales, Dividend Raised",
    "url": "https://finnhub.io/api/news?id=97285ecd7479d14351461180684a93543117126d6d7a7163b37ad85f18362214",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739289720,
      "headline": "Gilead Sciences 4Q Profit Up on HIV Product Sales, Dividend Raised",
      "id": 132684219,
      "image": "",
      "related": "GILD",
      "source": "MarketWatch",
      "summary": "Gilead Sciences 4Q Profit Up on HIV Product Sales, Dividend Raised",
      "url": "https://finnhub.io/api/news?id=97285ecd7479d14351461180684a93543117126d6d7a7163b37ad85f18362214"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences: Diversification Strategy Not Derisked Enough Yet",
    "summary": "Gilead Sciences faces revenue growth challenges as its blockbuster drugs lose exclusivity by 2033. Check out my recommendation for GILD stock.",
    "url": "https://finnhub.io/api/news?id=6ca7d2da2fa08baa5542c2235e7acee5730fafed01109fb5f717fb80f89bba9f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739243078,
      "headline": "Gilead Sciences: Diversification Strategy Not Derisked Enough Yet",
      "id": 132656676,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1189813806/image_1189813806.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Gilead Sciences faces revenue growth challenges as its blockbuster drugs lose exclusivity by 2033. Check out my recommendation for GILD stock.",
      "url": "https://finnhub.io/api/news?id=6ca7d2da2fa08baa5542c2235e7acee5730fafed01109fb5f717fb80f89bba9f"
    }
  },
  {
    "ts": null,
    "headline": "Q4 Earnings Growth Continues To Climb Despite Mixed Tech Results",
    "summary": "Q4 S&P 500 EPS growth expected to come in at 16.4%, the highest growth rate in three years. Read more here.",
    "url": "https://finnhub.io/api/news?id=8dcc76797f66a6433bc633aae8fb6f8a6380ea23097b3c694328c722121c836e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739239800,
      "headline": "Q4 Earnings Growth Continues To Climb Despite Mixed Tech Results",
      "id": 132656521,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1084171152/image_1084171152.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Q4 S&P 500 EPS growth expected to come in at 16.4%, the highest growth rate in three years. Read more here.",
      "url": "https://finnhub.io/api/news?id=8dcc76797f66a6433bc633aae8fb6f8a6380ea23097b3c694328c722121c836e"
    }
  }
]